Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesSyndromeAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationHematopoiesisRecurrenceCombined Modality TherapyMice, Inbred C57BLRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteBone Marrow ExaminationTreatment OutcomeImmunosuppressive AgentsRemission InductionTime FactorsHematologic NeoplasmsGraft RejectionHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingMyelodysplastic SyndromesBone Marrow NeoplasmsTransplantation ImmunologyLeukemia, MyeloidGraft vs Host ReactionAcute DiseaseImmunosuppressionLymphocyte DepletionStem Cell TransplantationLymphoma, Non-HodgkinLeukocyte TransfusionHeart TransplantationSevere Combined ImmunodeficiencyRetrospective StudiesT-LymphocytesChimeraSurvival AnalysisColony-Forming Units AssayHLA AntigensLung TransplantationHematologic DiseasesCyclosporineBone DensityActuarial AnalysisLymphocyte TransfusionNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesPancytopeniaCarmustineOrgan TransplantationCell DifferentiationGraft vs Tumor EffectLeukocyte CountSurvival RateCytarabineGraft vs Leukemia EffectCytomegalovirus InfectionsSpleenBone ResorptionGranulocyte Colony-Stimulating FactorMelphalanMice, Inbred BALB CFatal OutcomeDisease-Free SurvivalFlow CytometryEtoposideLymphomaMultiple MyelomaCells, CulturedPrognosisMice, KnockoutImmunologic Deficiency SyndromesAntigens, CD34Hodgkin DiseaseInfectionCell Transplantation